INTRODUCTION
============

Since the first experiment that showed a direct evidence for the existence of a strand-directed mismatch repair (MMR) in bacteria in 1976 ([@gkr1298-B1]), several thousand papers describing MMR *in vivo* and *in vitro* have been published ([@gkr1298-B2; @gkr1298-B3; @gkr1298-B4; @gkr1298-B5]). MMR is a major guardian of genomic stability that improves the fidelity of DNA replication ([@gkr1298-B6]), prevents genomic rearrangements ([@gkr1298-B7]) and acts as genetic barrier between related species ([@gkr1298-B8]) by abolishing recombination between non-identical DNA sequences ([@gkr1298-B2],[@gkr1298-B6]). Key bacterial MMR proteins, MutS and MutL, are conserved in all kingdoms of life ([@gkr1298-B2],[@gkr1298-B6]). The MutS protein, and its eukaryotic homologs, detects and binds diverse mismatches arising during DNA replication. The MutL protein, and its eukaryotic homologs, links a mismatch-bound MutS with the strand discrimination site of helicase/exonuclease activities that remove the mismatched base specifically from the newly synthesized strand.

In *Escherichia coli*, discrimination between template and newly synthesized strand is based on the methylation status of adenines in the GATC sequences ([@gkr1298-B2],[@gkr1298-B6]). In newly synthesized strands, adenines in GATC sequences are transiently unmethylated thus providing a binding site for the MutH endonuclease. MutH is a MutL-binding protein that can cleave the newly synthesized strand at a proximal non-methylated GATC sequence on either side of the mismatch ([@gkr1298-B2],[@gkr1298-B6]). DNA cleavage by MutH triggers mismatch repair involving UvrD (helicase II), single-stranded exonucleases, DNA polymerase III holoenzyme, single-strand DNA-binding protein and DNA ligase ([@gkr1298-B2],[@gkr1298-B6]). In *E. coli*, GATC cleavage can occur even at kilobase or larger distances from the mismatch ([@gkr1298-B6],[@gkr1298-B9]).

Despite the decades of research, a key mechanistic aspect of mismatch repair remained mysterious, i.e. what is the nature of molecular communication between the site of mismatch and the site of strand discrimination? Several conceptually exclusive models, which can be grouped into three categories, have been proposed to explain interaction between these two DNA sites. All models are based exclusively on *in vitro* biochemical studies of MMR proteins and there are yet no *in vivo* experiments that confirm their biological relevance. The first model postulates that DNA looping brings the stationary mismatch--MutS--MutL complex and the hemi-methylated GATC sequence in proximity ([@gkr1298-B10; @gkr1298-B11; @gkr1298-B12]). The second model proposes that MutS--MutL complex, or MutS alone, travel along the DNA helix from the mismatch towards the proximal strand discrimination site ([@gkr1298-B13],[@gkr1298-B14]). Finally, the third model suggests that mismatch recognition by MutS triggers polymerization of MutL along DNA between the mismatch and the strand discrimination signal ([@gkr1298-B15]). This model was promulgated by studies showing that MutS binding to the mismatch protects ∼10 bp on either side of the mismatch against DNase I digestion, while the addition of MutL extends the footprint dramatically ([@gkr1298-B11],[@gkr1298-B16]). Also the study of the effect of the DNA chain length on the formation of the ternary complex mismatch--MutS--MutL led to the proposal that the ternary complex formation could involve the polymerization of MutL along the helix ([@gkr1298-B17]). A corollary of this model is the assumption that more MutL than MutS proteins should be required for the repair of a mismatch. This was further strengthened by genetic evidence showing that the cellular level of MutL, and not of MutS, becomes limiting when MMR is saturated in the presence of numerous mismatches ([@gkr1298-B18; @gkr1298-B19; @gkr1298-B20; @gkr1298-B21; @gkr1298-B22]). Because both MutS and MutL are present in equimolar concentrations in the cell, MutL protein limitation cannot simply be due to a lower amount of MutL in the cell ([@gkr1298-B23]).

In this study, we looked whether more MutL than MutS proteins are present on the mismatches *in vivo*. We investigated individual growing *E. coli* cells carrying functional MutS and MutL proteins fused to fluorescent proteins and followed the formation of the fluorescent MMR protein complexes on individual mismatches in real-time by fluorescent microscopy. Our previously published data show that the MutL forms fluorescent foci on unrepairable mismatches and that MutL foci formation is dependent on MutS ([@gkr1298-B24]). However, the expected co-localization of MutS and MutL was not explored and the relative amount of MutS and MutL on these mismatches was not quantified. Here, we show that MutL and MutS fluorescent foci co-localize and that the fluorescence of MutL foci is always more intense than the fluorescence of MutS foci. Furthermore, the presence of a roadblock at the GATC sequences reduces the amount of MutL on the mismatch. This indicates that the *in vivo* accumulation of the MutL protein around mismatch is spanning the mismatch site and the site of strand discrimination. In conclusion, our results corroborate the hypothesis postulating that MutL polymerization could account for the communication between two distant DNA sites involved in MMR.

MATERIALS AND METHODS
=====================

*Escherichia coli* strains expressing fluorescently tagged MutL and MutS
------------------------------------------------------------------------

To assess the co-localization of MutS and MutL proteins in single *E. coli* cells, we constructed translational fusions of Yellow Fluorescent Protein (YFP) and Cyan Fluorescent Protein (CFP) to the N-termini of MutS and MutL proteins. This was done by modifying the plasmids peGFP-MutS^wt^ and peGFP-MutL^wt^ ([@gkr1298-B24]) in several steps. First, we replaced eGFP in the peGFP-MutL^wt^ and peGFP-MutS^wt^ by YFP and CFP. We amplified by PCR the fragment encoding YFP from the template pUC18-yfp ([@gkr1298-B25]) and the fragment encoding CFP from the template pUC18-cfp ([@gkr1298-B26]). We used primers 5′CCCAGATCTGGGTACCGACGACGACGACAAGATGGCTAGCAAAGGAGAACTTTTCAC-3 and 5′ATGAATTCGCCAGATCCTGATCCTGATCCAGATCCTGAGCCGCTTGGTAGAGCTCATCCATGCCATGTG-3 for *yfp* amplification. For *cfp* amplification, we used primers 5′CCCAGATCTGGGTACCGACGACGACGACAAGATGGCTAGCAAAGGAGAAGAACTTTTCAC-3′ and 5′TGAATTCGCCAGATCCTGATCCAGATCCTGAGCCGCTGATATCATCTTTGTAGAGCTCATCCATGCCATGTG-3′. These primer pairs include a BglII restriction site at the N-terminal and an EcoRI (for *yfp*) or an EcoRV restriction site (for *cfp*) at the C-terminal. We digested the PCR-amplified fragments by BglII and by EcoRI or EcoRV and cloned them in the peGFP-MutS^wt^ or peGFP-MutL^wt^. This resulted in the plasmids pYFP-MutS, pCFP-MutS, pYFP-MutL and pCFP-MutL expressing YFP-MutS, CFP-MutS, YFP-MutL and CFP-MutL, respectively. In the second step, we cloned the compatible fluorescent versions of *mutL* and *mutS* on the same plasmid, each under control of the individual T7 RNA polymerase promoter. We used the plasmids pCFP-MutS and pCFP-MutL as templates for PCR amplification of the fragments encoding CFP-MutS and CFP-MutL and including T7 RNA polymerase promoter and terminator. We used for PCR amplification primers 5′-GGGCATGCTAATACGACTCACTATAGGG-3′ and 5′-GGGCATGCCAAAAAACCCTCAAGACCCG-3′ with a SphI restriction site at the N- and C-termini. We digested PCR products by SphI and cloned the digested fragment in SphI site of the pYFP-MutL or pYFP-MutS. This resulted in the plasmid pYFP-MutL CFP-MutS expressing YFP-MutL and CFP-MutS, and the plasmid pYFP-MutS CFP-MutL expressing YFP-MutS and CFP-MutL. These plasmids were introduced in cells with inactivated chromosomal *mutS* and *mutL* genes*.*

To carry out experiments in which we determine the effect of the roadblock protein MutHE56A on MutL focus fluorescence, we cloned wild-type or partial loss-of-function *mutH* (*mutHE56A*) allele on the pBAD24 plasmid under arabinose promoter ([@gkr1298-B27]) and expressed *yfp* tagged *mutL* from lactose promoter on the chromosome.

To construct pBAD24 plasmids expressing MutH^wt^ or MutHE56A, we amplified by PCR the fragment encoding MutH^wt^ using pTX417 as a template, and the fragment encoding MutHE56A using as a template pWY1016 ([@gkr1298-B28],[@gkr1298-B29])*.* We used for PCR amplification primers 5′-GCGAATTCATGTCCCAACCTCGCCCACT-3′ and 5′-GGAAGCTTCTACTGGATCAGAAAATGAC-3′ with an EcoRI restriction site at the N-terminal and a HindIII restriction site at the C-terminal. We digested the obtained PCR products by EcoRI and HindIII and cloned them in the pBAD24*.* This resulted in the plasmids pBAD24MutH^wt^ or pBAD24MutHE56A expressing MutH^wt^ or MutHE56A.

For *yfp-mutL* integration in the chromosome, we first modified the plasmid pYFP-MutL to include the chloramphenicol resistance cassette (Cm^R^), flanked by FLP recombinase recognition targets, downstream of *mutL*. We amplified the sequence coding for the Cm^R^ (*cat*) by PCR using as a template the plasmid pKD3 ([@gkr1298-B30]). We used for PCR amplification primers 5′-CCGCGGCCGCGTGTAGGCTGGAGCTGCTTC-3′ and 5′-CCGCGGCCGCCATATGAATATCCTCCTTAG-3′ including a NotI restriction site at the N- and C-termini. We digested the resulting PCR product by NotI and cloned it in NotI site of the pYFP-MutL. This resulted in the plasmid pYFP-MutLCm^R^. In a second step, we used the pYFP-MutLCm^R^ as a template to clone the *yfp-mutL-cat* under lactose promoter on the chromosome using gene replacement technique ([@gkr1298-B30]). We amplified the *yfp-mutL-cat* by PCR using primers that include homologies to the chromosomal lactose region. The primer 1 (5′-TGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGGCTAGCAAAGGAGAAGAAC-3′) includes at 5′ 45 bp sequence homologous to lactose promoter region (from −1 to −45) and the primer 2 (5′- CACCAGACCAACTGGTAATGGTAGCGACCGGCGCTCAGCTGTTAGCAGCCGGATCTCAGTG-3′) includes at 5′ 40 bp sequence homologous to *lacZ* C terminal (from 3026 to 3065). The resulting PCR product was introduced by transformation in MG1655 *mutL218*::Tn10 strain containing the plasmid pKD46 ([@gkr1298-B30]). The selected chloramphenicol resistant lactose^−^ clones were named ME120.

Strains, growth conditions and mutation frequency assays
--------------------------------------------------------

Strains and plasmids are listed in [Supplementary Tables S1](http://nar.oxfordjournals.org/cgi/content/full/gkr1298/DC1) and [S2](http://nar.oxfordjournals.org/cgi/content/full/gkr1298/DC1). All strains were derived from wild-type *E. coli* MG1655 strain using P1 transduction and transformation. We verified strain genotypes by testing the UV resistance, capacity to generate mutations conferring resistance to rifampicin or ability to use arabinose in McConkey plates supplemented by arabinose. We grew cells in M9 medium ([@gkr1298-B31]) supplemented by 2 mM MgSO~4~, 0.003% vitamin B1, 0.001% uracile, 0.2% casamino acids, 0.01% glycerol and ampicillin (100 μg/ml) (to select for plasmids expressing the fluorescently labeled derivatives of MMR proteins). We added arabinose (0.02%) to the growth medium to induce the expression of MutHE56A or MutH^wt^ above their basal level of expression from the pBAD24 plasmid. To block DNA replication we used rifampicin at 150 μg/ml. We performed mutagenesis experiments as described previously ([@gkr1298-B24]).

Live cell microscopy
--------------------

Microscopy of live cells was done as described previously ([@gkr1298-B24]). Briefly, we grew cells in supplemented M9 medium to early exponential phase (OD~600~ 0.1--0.2) at 37°C. When indicated, cultures were split in two. We treated one culture with rifampicin for 30 min, while the other culture was not treated. We concentrated the aliquots of treated and untreated cells and spread them on supplemented M9 agarose medium, in a cavity slide to obtain a cell monolayer, as described previously ([@gkr1298-B24]). We mounted the slide on Metamorph software (Universal Imaging) driven temperature controlled (Life Imaging Services) Zeiss 200M (Zeiss) inverted microscope. Images were recorded at 100-fold (for MutS/MutL co-localization experiments and for MutL foci fluorescence experiments of rifampicin treated or untreated cells) or 63-fold magnification (for roadblock experiments) using CoolSNAP HQ camera (Princton Instruments), in phase contrast and in fluorescence. Co-localization experiments and MutL foci fluorescence experiments of rifampicin treated or untreated cells we done using HBO 103 lamp (Zeiss) regulated to 100% power at wavelengths of 500 nm (YFP) and 420 nm (CFP) during 20 s (for YFP and eGFP) and 6 s (for CFP) of exposure time. Roadblock experiments were done with HXP 120 lamp (Zeiss) regulated to 100% power at wavelength of 500 nm (YFP) during 6 s of exposure time. We acquired, merged and analyzed images using Metamorph software (Meta Imaging Systems).

Image analysis
--------------

Images were analyzed as described previously ([@gkr1298-B24]). Briefly, for all foci, we defined the region delimiting each focus, and one control region in the cell, representing the cytoplasmic fluorescence, using Metamorph region tool. For the co-localization analysis, we defined two regions (focus and control) first on the fluorescent image taken with the yellow filter. That was the image that we always recorded first. We then transferred both regions to the same position on the fluorescent image taken with the blue filter and measured the fluorescence of the control and focus regions for each cell, and for each image. We also recorded the fluorescence background of the agarose for each image. We calculated focus fluorescence by subtracting from the maximal pixel intensity of focus region the average fluorescence of control region. The cytoplasmic fluorescence was determined by subtracting from the average fluorescence of the control region the average fluorescence of the background. All presented data are the cumulative from at least three independent experiments, which always showed similar results.

RESULTS
=======

Fluorescently tagged MutS and MutL are functional
-------------------------------------------------

Using GFP-MutL fusion, we and Walker\'s group showed previously that MutL forms MutS-dependent fluorescent foci on mismatches in growing *E. coli* and *Bacillus subtilis* cells ([@gkr1298-B24],[@gkr1298-B32]). While the *B. subtilis* fluorescent MutL was non-functional, the *E. coli* one that we constructed conserved its function completely. For this study, we constructed YFP- and CFP-tagged MutL and MutS. To determine whether these fluorescent protein fusions are functional, we examined their ability to complement the deletions of *mutS* and *mutL* genes ([Figure 1](#gkr1298-F1){ref-type="fig"}A and [Supplementary Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkr1298/DC1)). The strains deleted for *mutL* and *mutS* carrying the plasmid expressing YFP-MutL and CFP-MutS, or carrying the plasmid expressing CFP-MutL and YFP-MutL, exhibited the spontaneous mutagenesis levels of the wild-type strain ([Figure 1](#gkr1298-F1){ref-type="fig"}A). On the other hand, the frequency of mutations of same *mutL* and *mutS* strains carrying only the empty vector was 200-fold higher than of the wild-type strain ([Figure 1](#gkr1298-F1){ref-type="fig"}A). Figure 1.Functional fluorescent MutL and MutS co-localize on DNA mismatches. (**A**) Mutation frequency of *mutL mutS* deletion strain expressing fluorescently labeled MutS and MutL. Fluorescent images (taken with yellow and blue filters) and overlay image of *mutH* strain expressing (**B**) YFP-MutL and CFP-MutS or (**C**) YFP-MutS and CFP-MutL. Mean and standard error of the mean are presented in panel A. Rif^R^ stands for rifampicin resistant.

MutL and MutS co-localize on mismatches
---------------------------------------

To investigate the mismatch repair reaction *in vivo*, we started by examining the co-localization of MutS and MutL. To do this, we used a mismatch repair deficient *mutH* strain to get higher number of mismatches in order to have better statistics. The frequency of cells bearing MutL foci in the *mutH* strain increased from 0.45% in the wild-type strain to 24.9% ([@gkr1298-B24]). The observed MutL foci are specific to mismatches because they are not formed without functional MutS protein ([@gkr1298-B24]). When we examined MutL foci, we found that they are co-localized with MutS foci. We quantified the frequency of co-localization and found that in 90% of cases MutL foci are co-localized with MutS foci ([Figure 1](#gkr1298-F1){ref-type="fig"}B and C). Since no MutL foci form in the absence of a functional MutS, we conclude that in the remaining 10% of cases MutS foci must be below the threshold of detection (see also below).

Relative stoichiometry of MutL and MutS
---------------------------------------

When the number of mismatches increases in the cell, MutL but not MutS becomes limiting ([@gkr1298-B18; @gkr1298-B19; @gkr1298-B20; @gkr1298-B21; @gkr1298-B22]). MutL could become limiting during MMR if the stoichiometry of the mismatch repair reaction is such that more MutL than MutS proteins are needed in the repair of a mismatch. This hypothesis predicts that the MutS and MutL foci co-localized on the mismatches should contain a greater amount of MutL than MutS protein. To compare the relative amount of MutS and MutL proteins per mismatch, we analyzed the fluorescence intensity of the co-localized MutS and MutL foci. First, we identified a MutL focus and the coincident MutS focus, and then we measured their respective fluorescent intensities. We performed these experiments with the combinations of YFP-MutL and CFP-MutS as well as with CFP-MutL and YFP-MutS protein fusions ([Figure 1](#gkr1298-F1){ref-type="fig"}B and C). In both cases, the fluorescence intensity of MutL foci was higher compared to the intensity of MutS foci ([Figure 2](#gkr1298-F2){ref-type="fig"}A). The average ratio of MutL foci fluorescence to co-localized MutS foci fluorescence was 2.7 ([Figure 2](#gkr1298-F2){ref-type="fig"}B). These differences are not due to differences in the cytoplasmic fluorescence that varies very little among cells carrying differently labeled MutS and MutL proteins ([Figure 2](#gkr1298-F2){ref-type="fig"}A). Figure 2.The stoichiometry of MutL and MutS on DNA mismatches. (**A**) The mean cytoplasmic fluorescence and the mean fluorescence of foci for 108 cells with YFP-MutL and CFP-MutS foci from 1B and 95 cells with YFP-MutS and CFP-MutL foci from 1C. (**B**) The histogram of the ratio of MutL focus fluorescence to co-localized MutS focus fluorescence for 203 pairs of co-localized MutL and MutS foci from A. (**C**) No correlation between the fluorescence intensity of co-localized foci of YFP-MutL and CFP-MutS (*R*^2^ = 0.09) and (**D**) YFP-MutS and CFP-MutL (*R*^2^ = 0.08). Error bars in A indicate standard error of the mean, *N* in B stands for number, a.u. in A, C and D stands for arbitrary units and fluo in C and D stands for fluorescence.

For the YFP-MutL CFP-MutS pairs, the mean YFP-MutL and CFP-MutS foci fluorescence (±SEM) was 230 (±17.6) and 73 (±2.7), respectively. For the YFP-MutS CFP-MutL pairs, the mean YFP-MutS and CFP-MutL foci fluorescence was 76 (±3.8) and 162 (±7.4), respectively. Observed differences between fluorescence intensity of MutL and MutS foci are statistically significant (*P* \< 0.0001, Wilcoxon test).

To examine the possible stoichiometric relationships of MutS and MutL co-assembled on mismatches, we examined the correlation between the intensity of fluorescence of the co-localized MutL and MutS in single foci. We detected no correlation between the MutL and MutS fluorescent intensities. For the YFP-MutL CFP-MutS pair, the *R*^2^ was 0.09 ([Figure 2](#gkr1298-F2){ref-type="fig"}C) and for the YFP-MutS CFP-MutL pair *R*^2^ was 0.08 ([Figure 2](#gkr1298-F2){ref-type="fig"}D). The absence of correlation demonstrates that, beyond the greater number of MutL than MutS molecules on mismatches noted above, there is no regularity in the stoichiometric relationship between MutS and MutL on mismatches.

Taken together, these results show that a greater number of MutL molecules than MutS are involved in the mismatch repair reaction.

Number of MutL molecules on mismatches is independent of the intracellular concentration of MutL
------------------------------------------------------------------------------------------------

Since, we established that MutL assembles in greater numbers on mismatches than MutS, we wondered if this was determined by the intracellular concentration of MutL. To examine this possibility, we quantified the cytoplasmic fluorescence of eGFP-MutL and examined its correlation with the fluorescence intensity of MutL foci. No correlation between these fluorescence intensities was seen ([Figure 3](#gkr1298-F3){ref-type="fig"}A). We conclude that the cytoplasmic concentration of MutL does not determine its amount assembled on mismatches. Figure 3.MutL amount on mismatches is independent of the intracellular concentration of MutL. No correlation between MutL focus fluorescence and cytoplasmic MutL fluorescence for (**A**) 131 foci without treatment (*R*^2^ = 0.007) and (**B**) 200 foci after 30-min treatment with rifamcipin (*R*^2^ = 0.004).

The absence of such correlation could result also from a limited life-time of the MutL foci ([@gkr1298-B24]). The disassembly of the MutL foci could affect the detection of any correlation between the amount of MutL in the cytoplasm and on mismatches. The disassembly of MutL foci depends on DNA replication ([@gkr1298-B24]). When replication initiation is blocked with rifampicin, the life-time of MutL foci is greatly increased, but their fluorescence does not increase ([@gkr1298-B24]). To test the possible effect of the disassembly of MutL foci on the correlation between the amount of MutL in the cytoplasm and on mismatches, we treated the cells with rifampicin in order to block the initiation of chromosome replication. There was also no correlation between the fluorescence intensity of the MutL foci and the cytoplasmic fluorescence in cells treated with rifampicin ([Figure 3](#gkr1298-F3){ref-type="fig"}B).

Together, these results confirm that the fluorescence of MutL foci depends on the number of MutL molecules in the focus and not on its intracellular concentration or on the life-time of the focus.

Roadblocks on DNA reduce the number of MutL molecules assembled on mismatches
-----------------------------------------------------------------------------

There are two possibilities as to why the mismatches lead to the accumulation of MutL. MutL could assemble along the DNA or it could form a complex that is not in contact with the DNA. These two possibilities can be distinguished by placing roadblocks on the DNA. If MutL assembles along the DNA, then such roadblocks would limit the number of MutL molecules in the foci. The decreased number of MutL molecules in the foci would decrease the foci fluorescence, or the frequency of foci, when the number of MutL molecules becomes insufficient for focus detection. If MutL forms a complex that does not make contact along the DNA, then such roadblocks would have no effect on the foci fluorescence or on the foci frequency.

The *mutHE56A* codes for a MutH protein that efficiently binds to GATC sequences *in vitro* without cleaving them ([@gkr1298-B29]). Due to this property, MutHE56A can be used as a roadblock on the GATC sequence proximal to a mismatch.

We first tested how the expression of MutHE56A affects the frequency of MutL foci in wild-type and in *mutH* cells. We showed previously that the frequency of fluorescent MutL foci corresponds closely to the mutation frequency of different strains examined ([@gkr1298-B24]). We found that the production of MutHE56A increases significantly the frequency of MutL foci in the wild-type cells compared to controls ([Figure 4](#gkr1298-F4){ref-type="fig"}A). We confirmed this result by a classical mutagenesis assay, i.e. we measured the frequency of appearance of spontaneous mutations conferring resistance to rifampicin in strains expressing MutHE56A and in the control wild-type strains ([Figure 4](#gkr1298-F4){ref-type="fig"}B). The results show that expression of MutHE56A increased spontaneous mutagenesis. Figure 4.Dominant negative effect of roadblock MutHE56A over wild-type MutH. MutHE56A expression in the wild-type cells increases significantly (**A**) the percentage of cells with at least 1 MutL focus (**B**) the frequency of rifampicin-resistant mutants, compared to controls (*P* \< 0.05, Wilcoxon test).

We interpret this result to be a consequence of a dominant negative effect of the mutant over the wild-type protein expressed from its native chromosomal site. The binding of MutHE56A to GATC sequences likely competes with MutH^wt^ rendering mismatch repair inefficient and explaining the increase in mutation frequency. *In vivo* dominant negative effect of MutHE56A is consistent with previous *in vitro* studies showing that MutHE56A binds GATC sequences as efficiently as MutH^wt^ but is completely defective for the DNA incision ([@gkr1298-B29]).

The expression of MutHE56A had no effect on the frequency of MutL foci in *mutH* cells compared to control cells ([Figure 5](#gkr1298-F5){ref-type="fig"}A), arguing that these cells were still MMR deficient. On the other hand, the expression of MutH^wt^ from a plasmid completely restored the MMR proficiency of the *mutH* cells. This was determined by measuring the frequency of YFP-MutL foci and the frequency of appearance of rifampicin resistant mutants (data not shown). These results are consistent with previous studies of mutation frequencies of *mutH* cells expressing MutHE56A or MutH^wt^ ([@gkr1298-B29]). Figure 5.Roadblock on strand discrimination site reduces the accumulation of MutL on DNA mismatches. (**A**) Percentage of cells with at least 1 MutL focus in *mutH* cells is not affected by MutHE56A expression (*P* \> 0.05, Wilcoxon test). (**B**) Fluorescent images of *mutH* cells expressing (a) fluorescent MutL alone or (b) fluorescent MutL and MutHE56A mutant. (**C**) The mean focus fluorescence for 150 foci from Ba and for 150 foci from Bb is significantly different (*P* \< 0.0001, Wilcoxon test). The mean cytoplasmic fluorescence for 90 cells from B(a) and 90 cells from B(b) is not significantly different (*P* \> 0.05, Wilcoxon test). (**D**) The histograms of MutL foci fluorescence for cells from B(a) and B(b). Error bars in A and C indicate the standard error of the mean. *n* in A and C indicates the number of cells/foci examined.

Finally, we examined the effect of MutHE56A expression on the amount of MutL associated with mismatches. We performed this experiment in *mutH* cells because they provide a large number of MutL foci, which is necessary for good statistics.

The fluorescence intensity of MutL foci was significantly lower in cells expressing MutHE56A compared to control cells that did not express this mutant protein (3-fold; *P* \< 0.0001, Wilcoxon test) ([Figure 5](#gkr1298-F5){ref-type="fig"}B--D). There was no difference in the intracellular concentration of MutL between the cells that expressed MutHE56A and those that did not, as judged by the fluorescence intensity of the cytoplasm ([Figure 5](#gkr1298-F5){ref-type="fig"}C). This result suggests that MutL foci are less fluorescent as binding of MutHE56A to GATC prevents MutL from accumulating further along DNA. However, the decrease in MutL foci fluorescence and the increase in mutation frequency observed in the presence of MutHE56A could also be due to occluding the binding sites on MutL by overproducing one of its binding partners, in our case MutH. If this is so, we expect that the overproduction *per se* of wild-type or mutant MutH should have the same effect. However, our data with overproduction of wild-type MutH eliminate this hypothesis ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkr1298/DC1)).

Taken together, our results suggest that MutL assembles along the DNA from the mismatch site toward a proximal unmethylated GATC sequences.

DISCUSSION
==========

MutL is a molecular matchmaker protein, which interacts with MutS, MutH and UvrD ([@gkr1298-B2],[@gkr1298-B6]). MutL interaction with the MutS--mismatch complex triggers MutH endonuclease activity at a distal-strand discrimination DNA site ([@gkr1298-B2],[@gkr1298-B6]). The nature of communication between these distal sites is not known. Several models based on *cis* and *trans* communication between these sites have been proposed ([@gkr1298-B10; @gkr1298-B11; @gkr1298-B12; @gkr1298-B13; @gkr1298-B14]). All of these models are based on *in vitro* studies and imply an equal stoichiometry of MutS and MutL proteins in the mismatch repair reaction. One hypothesis, that still awaits experimental evidence, suggests that the accumulation of MutL on DNA could allow the establishment of a physical interaction between the mismatch--MutS complex and the strand discrimination site ([@gkr1298-B15]). There are two predictions of this hypothesis that could be tested *in vivo*. The first is that the *in vivo* stoichiometry of mismatch repair involves more MutL than MutS molecules. The second is that a steric block on the DNA around a mismatch prevents the accumulation of MutL.

We used functional fluorescent MutS and MutL proteins to test these predictions. We found that MutS and MutL co-localize on mismatches in visible foci and that MutL foci are, on average, 2.7 times more intense than the co-localized MutS foci. These results indicate that the stoichiometry of the mismatch repair reaction *in vivo* involves more molecules of MutL than MutS. There is a caveat to this interpretation. Mismatch--MutS--MutL complexes that we are detecting are forming on mismatches that are unrepairable, due to *mutH* deficiency. It is possible that MutS and MutL stoichiometry on repairable mismatches is different from the one that we observe.

Our results on MutS and MutL stoichiometry on unrepaired mismatches are consistent with the *in vitro* DNA footprinting studies that show that MutS alone covers about 20 bp around mismatch, but that the addition of MutL increases considerably the size of the footprint (to 143 bp or more) ([@gkr1298-B11],[@gkr1298-B16]). Our calculations, based on the resolved structure of MutS and on the model of the intact MutL ([@gkr1298-B33; @gkr1298-B34; @gkr1298-B35; @gkr1298-B36]), predict that one MutS dimer protects ∼20 bp while one MutL dimer covers ∼10 bp. Therefore, the extensive coverage of DNA seen in the presence of MutL is most likely due to the binding of multiple MutL proteins to the MutS-bound mismatch.

The second prediction of the model that suggests that MutL contacts the DNA while it accumulates around a mismatch is that a steric block on the GATC, proximal to the mismatch, would limit the amount of accumulated MutL. We used a mutant MutH protein, MutHE56A, which is able to bind to GATC sequences, but cannot cleave them. This protein was dominant negative when present in the cell and it reduced the amount of MutL present around mismatches. This is consistent with the idea that MutL contacts the DNA as it accumulates around a mismatch. This notion also suggests that MutL has at least two sites of where it can bind around a mismatch, to another MutL molecule and to the DNA. This predicts that the binding of MutL to the DNA could be cooperative. Indeed, it was shown that *E. coli* MutL*,* as well as its homologs, Mlh1-Pms1, bind DNA cooperatively *in vitro* ([@gkr1298-B37],[@gkr1298-B38]).

On the account of the *in vivo* results presented here, and previous genetic and biochemical studies on MMR proteins, we propose the following model for *in vivo* MMR mechanism. Upon initial binding of MutS to a mismatch, MutS may diffuse and translocate along the DNA helix hence allowing additional copies of MutS to be loaded. Such repetitive MutS loading on mismatch is predicted by MMR models that involve movement of MMR proteins along the helix contour ([@gkr1298-B14],[@gkr1298-B17]). Iterative binding of MutS to mismatches could explain the appearance of MutS foci *in vivo*. Binding of MutL to mismatch-bound MutS prevents MutS from sliding away as suggested by a study reporting an increased half-life of MutS--heteroduplex DNA complex upon MutL addition ([@gkr1298-B10]). Presumably, MutL does not affect MutS that is bound to mismatch but it interacts with MutS that slid away ([@gkr1298-B14]). MutL binding to DNA-bound MutS forms a ternary complex and establishes a nucleation point for further MutL accumulation on DNA surrounding the mismatch. *Escherichia coli* MutS tetramerization domain structure reveals that stable dimers but not tetramers are essential for DNA mismatch repair *in vivo* ([@gkr1298-B39]). A homodimeric MutS might be able to interact with two MutL dimers, which would lead to a ratio of MutL:MutS of 2 that is close to the observed values (2.1, for the combination of CFP-MutL and YFP-MutS, and 3.2 for the combination of YFP-MutS and CFP-MutL). However, our results show (data not shown) that, in all combinations, the fluorescence of MutS and MutL foci is highly variable and that the coefficient of variation of foci fluorescence is similar for differently labeled MutS and MutL. This suggests that not just one MutS and two MutL dimers accumulate on unrepaired mismatches but several MutS dimers and on average twice more dimers of MutL. We hypothesize that MutS--MutL--DNA filament-like structure is dynamic. A static filament might be inhibitory for strand discrimination as the binding of MutL to the DNA in a filament like manner could occlude the GATC sites similar as in MutS--MutL--DNA footprinting experiments ([@gkr1298-B11],[@gkr1298-B16]).

Why may *in vivo* MMR require multiple MutL molecules? The average distance between two adjacent GATC sequences in *E. coli* genome is 256 bp. Except for runs of repeated mono-, di- and tri-nucleotides, the replicative DNA polymerase presumably makes errors randomly. Therefore, mismatches can be found anywhere in between two adjacent GATCs. So, the average distances between the mismatch and the proximal GATC are between 1 and 125 bp. Therefore, longer distances between mismatch and proximal GATC require accumulation of multiple copies of MutS and MutL proteins. In the light of our results, it would be interesting to test if the regions with low GATC abundance are more prone to mutations due to the requirement of higher numbers of the MutL protein, which appears to be in limiting quantity for replication fidelity control ([@gkr1298-B40]) as well as for recombination between non identical DNA sequences ([@gkr1298-B41]).

Our findings are also relevant for the understanding of the phenomenon of MutL saturation *in vivo*. MMR system has limited capacity to repair DNA mismatches: it saturates when the number of mismatches increases in the cell above a certain threshold. It was shown in several studies that MMR saturation is a result of MutL limitation, and not of limitation of MutS ([@gkr1298-B18; @gkr1298-B19; @gkr1298-B20; @gkr1298-B21; @gkr1298-B22]). However, the cause of MutL limitation was not identified. The simple possibility that MutL limitation is due to a lower amount of MutL in cell was excluded as both MutL and MutS are present in cells in equimolar concentrations ([@gkr1298-B23]). We found that treatments, which saturate MutL, do not lead to degradation of MutL that could lead to the deficit of functional MutL (Elez, M. and Radman, M., unpublished data). Therefore, in the light of our results, we propose that the deficit of MutL under conditions which increase the load of mismatches in cells could be due to engagement of more MutL than MutS proteins on the DNA mismatches. Unlike MutS, MutL associates with other members of the mismatch repair pathway in *E. coli*, the stoichiometry of which is unclear. This added involvement of MutL could also be an additional reason for MutL becoming saturating instead of MutS.

The MMR mechanism that involves more MutL accumulation relative to MutS observed in this study could be evolutionary conserved. For example, while this article was in revision, Kolodner\'s group published the article demonstrating the mechanism of MMR in yeast using the same *in vivo* approach as we did here ([@gkr1298-B42]). They reported that the mismatch recognition by Msh2--Msh6 directs formation of superstoichiometric Mlh1-Pms1 foci.
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